Detalhe da pesquisa
1.
The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3ß and MyD88/NF-κB signalling pathways.
Exp Cell Res
; 394(2): 112157, 2020 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32610185
2.
A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-ß1-Induced EMT in Vivo and in Vitro.
Kidney Blood Press Res
; 43(5): 1677-1687, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30380557